X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Certara will support the DMTC led clinical trial by analyzing study data to develop mathematical models to understand viral time course and factors impacting drug exposure and prophylactic response.
Lead Product(s): Chloroquine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Phase IVProduct Type: Small molecule
Recipient: Defence Materials Technology Centre
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration May 07, 2020
Details:
Certara’s D360 platform enables Arvinas to accelerate lead identification and optimization processes for oncology, neurodegenerative diseases, and therapies for “undruggable” targets.
Lead Product(s): Proteolysis targeting chimera
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Arvinas
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership February 10, 2020
Details:
Certara's Simcyp population-based Simulator was used to support Galderma’s successful U.S. FDA new drug application for AKLIEF (trifarotene) Cream, 0.005% for the topical treatment of acne.
Lead Product(s): Trifarotene
Therapeutic Area: Dermatology Product Name: Aklief
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Galderma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership January 08, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
